NCT00640458View on ClinicalTrials.gov

Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

March 31, 2007

Conditions

Female Sexual Arousal Disorder

Interventions

DRUG

Sildenafil 100 mg

DRUG

Placebo

Trial Locations (3)

6009

Pfizer Investigational Site, Nedlands

98105

Pfizer Investigational Site, Seattle

98195-6465

Pfizer Investigational Site, Seattle

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00640458 - Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder | Biotech Hunter | Biotech Hunter